')}.amp-carousel-button-prev{background-image:url('data:image/svg+xml;charset=utf-8,Previous ')}.ampstart-dropdown{min-width:200px}.ampstart-dropdown.absolute{z-index:100}.ampstart-dropdown.absolute>section,.ampstart-dropdown.absolute>section>header{height:100%}.ampstart-dropdown>section>header{background-color:#000;border:0;color:#fff}.ampstart-dropdown>section>header:after{display:inline-block;content:"+";padding:0 0 0 1.5rem;color:#003f93}.ampstart-dropdown>[expanded]>header:after{content:"�"}.absolute .ampstart-dropdown-items{z-index:200}.ampstart-dropdown-item{background-color:#000;color:#003f93;opacity:.9}.ampstart-dropdown-item:active,.ampstart-dropdown-item:hover{opacity:1}.ampstart-footer .ampstart-icon{fill:#000}.ampstart-footer .ampstart-social-follow li:last-child{margin-right:0}.ampstart-image-fullpage-hero{color:#fff}.ampstart-fullpage-hero-heading-text,.ampstart-image-fullpage-hero .ampstart-image-credit{-webkit-box-decoration-break:clone;box-decoration-break:clone;background:#000;padding:0 1rem .2rem}.ampstart-image-fullpage-hero>amp-img{max-height:calc(100vh - 3.5rem)}.ampstart-image-fullpage-hero>amp-img img{-o-object-fit:cover;object-fit:cover}.ampstart-fullpage-hero-heading{line-height:3.5rem}.ampstart-fullpage-hero-cta{background:transparent}.ampstart-readmore{background:-webkit-linear-gradient(bottom,rgba(0,0,0,.65),transparent);background:linear-gradient(0deg,rgba(0,0,0,.65),transparent);color:#fff;margin-top:5rem;padding-bottom:3.5rem}.ampstart-readmore:after{display:block;content:"?";font-size:2rem}.ampstart-readmore-text{background:#000}@media (min-width:52.06rem){.ampstart-image-fullpage-hero>amp-img{height:60vh}}.ampstart-image-heading{color:#fff;background:-webkit-linear-gradient(bottom,rgba(0,0,0,.65),transparent);background:linear-gradient(0deg,rgba(0,0,0,.65),transparent)}.ampstart-image-heading>*{margin:0}amp-carousel .ampstart-image-with-heading{margin-bottom:0}.ampstart-image-with-caption figcaption{color:#4f4f4f;line-height:1.125rem}amp-carousel .ampstart-image-with-caption{margin-bottom:0}.ampstart-input{max-width:100%;width:300px;min-width:100px;font-size:1rem;line-height:1.5rem}.ampstart-input [disabled],.ampstart-input [disabled]+label{opacity:.5}.ampstart-input [disabled]:focus{outline:0}.ampstart-input>input,.ampstart-input>select,.ampstart-input>textarea{width:100%;margin-top:1rem;line-height:1.5rem;border:0;border-radius:0;border-bottom:1px solid #4a4a4a;background:none;color:#4a4a4a;outline:0}.ampstart-input>label{color:#003f93;pointer-events:none;text-align:left;font-size:.875rem;line-height:1rem;opacity:0;-webkit-animation:.2s;animation:.2s;-webkit-animation-timing-function:cubic-bezier(.4,0,.2,1);animation-timing-function:cubic-bezier(.4,0,.2,1);-webkit-animation-fill-mode:forwards;animation-fill-mode:forwards}.ampstart-input>input:focus,.ampstart-input>select:focus,.ampstart-input>textarea:focus{outline:0}.ampstart-input>input:focus::-webkit-input-placeholder,.ampstart-input>select:focus::-webkit-input-placeholder,.ampstart-input>textarea:focus::-webkit-input-placeholder{color:transparent}.ampstart-input>input:focus::-moz-placeholder,.ampstart-input>select:focus::-moz-placeholder,.ampstart-input>textarea:focus::-moz-placeholder{color:transparent}.ampstart-input>input:focus:-ms-input-placeholder,.ampstart-input>select:focus:-ms-input-placeholder,.ampstart-input>textarea:focus:-ms-input-placeholder{color:transparent}.ampstart-input>input:focus::placeholder,.ampstart-input>select:focus::placeholder,.ampstart-input>textarea:focus::placeholder{color:transparent}.ampstart-input>input:not(:placeholder-shown):not([disabled])+label,.ampstart-input>select:not(:placeholder-shown):not([disabled])+label,.ampstart-input>textarea:not(:placeholder-shown):not([disabled])+label{opacity:1}.ampstart-input>input:focus+label,.ampstart-input>select:focus+label,.ampstart-input>textarea:focus+label{-webkit-animation-name:a;animation-name:a}@-webkit-keyframes a{to{opacity:1}}.ampstart-input>label:after{content:"";height:2px;position:absolute;bottom:0;left:45%;background:#003f93;-webkit-transition:.2s;transition:.2s;-webkit-transition-timing-function:cubic-bezier(.4,0,.2,1);transition-timing-function:cubic-bezier(.4,0,.2,1);visibility:hidden;width:10px}.ampstart-input>input:focus+label:after,.ampstart-input>select:focus+label:after,.ampstart-input>textarea:focus+label:after{left:0;width:100%;visibility:visible}.ampstart-input>input[type=search]{-webkit-appearance:none;-moz-appearance:none;appearance:none}.ampstart-input>input[type=range]{border-bottom:0}.ampstart-input>input[type=range]+label:after{display:none}.ampstart-input>select{-webkit-appearance:none;-moz-appearance:none;appearance:none}.ampstart-input>select+label:before{content:"?";line-height:1.5rem;position:absolute;right:5px;zoom:2;top:0;bottom:0;color:#003f93}.ampstart-input-chk,.ampstart-input-radio{width:auto;color:#4a4a4a}.ampstart-input input[type=checkbox],.ampstart-input input[type=radio]{margin-top:0;-webkit-appearance:none;-moz-appearance:none;appearance:none;width:20px;height:20px;border:1px solid #003f93;vertical-align:middle;margin-right:.5rem;text-align:center}.ampstart-input input[type=radio]{border-radius:20px}.ampstart-input input[type=checkbox]:not([disabled])+label,.ampstart-input input[type=radio]:not([disabled])+label{pointer-events:auto;-webkit-animation:none;animation:none;vertical-align:middle;opacity:1;cursor:pointer}.ampstart-input input[type=checkbox]+label:after,.ampstart-input input[type=radio]+label:after{display:none}.ampstart-input input[type=checkbox]:after,.ampstart-input input[type=radio]:after{position:absolute;top:0;left:0;bottom:0;right:0;content:" ";line-height:1.4rem;vertical-align:middle;text-align:center;background-color:#fff}.ampstart-input input[type=checkbox]:checked:after{background-color:#003f93;color:#fff;content:"?"}.ampstart-input input[type=radio]:checked{background-color:#fff}.ampstart-input input[type=radio]:after{top:3px;bottom:3px;left:3px;right:3px;border-radius:12px}.ampstart-input input[type=radio]:checked:after{content:"";font-size:3rem;background-color:#003f93}.ampstart-input>label,_:-ms-lang(x){opacity:1}.ampstart-input>input:-ms-input-placeholder,_:-ms-lang(x){color:transparent}.ampstart-input>input::placeholder,_:-ms-lang(x){color:transparent}.ampstart-input>input::-ms-input-placeholder,_:-ms-lang(x){color:transparent}.ampstart-input>select::-ms-expand{display:none}.ampstart-headerbar{background-color:#fff;color:#000;z-index:999;box-shadow:0 0 5px 2px rgba(0,0,0,.1)}.ampstart-headerbar+:not(amp-sidebar),.ampstart-headerbar+amp-sidebar+*{margin-top:3.5rem}.ampstart-headerbar-nav .ampstart-nav-item{padding:0 1rem;background:transparent;opacity:.8}.ampstart-headerbar-nav{line-height:3.5rem}.ampstart-nav-item:active,.ampstart-nav-item:focus,.ampstart-nav-item:hover{opacity:1}.ampstart-navbar-trigger:focus{outline:none}.ampstart-nav a,.ampstart-navbar-trigger,.ampstart-sidebar-faq a{cursor:pointer;text-decoration:none}.ampstart-nav .ampstart-label{color:inherit}.ampstart-navbar-trigger{line-height:3.5rem;font-size:2rem}.ampstart-headerbar-nav{-webkit-box-flex:1;-ms-flex:1;flex:1}.ampstart-nav-search{-webkit-box-flex:0.5;-ms-flex-positive:0.5;flex-grow:0.5}.ampstart-headerbar .ampstart-nav-search:active,.ampstart-headerbar .ampstart-nav-search:focus,.ampstart-headerbar .ampstart-nav-search:hover{box-shadow:none}.ampstart-nav-search>input{border:none;border-radius:3px;line-height:normal}.ampstart-nav-dropdown{min-width:200px}.ampstart-nav-dropdown amp-accordion header{background-color:#fff;border:none}.ampstart-nav-dropdown amp-accordion ul{background-color:#fff}.ampstart-nav-dropdown .ampstart-dropdown-item,.ampstart-nav-dropdown .ampstart-dropdown>section>header{background-color:#fff;color:#000}.ampstart-nav-dropdown .ampstart-dropdown-item{color:#003f93}.ampstart-sidebar{background-color:#fff;color:#000;min-width:300px;width:300px}.ampstart-sidebar .ampstart-icon{fill:#003f93}.ampstart-sidebar-header{line-height:3.5rem;min-height:3.5rem}.ampstart-sidebar .ampstart-dropdown header,.ampstart-sidebar .ampstart-dropdown-item,.ampstart-sidebar .ampstart-faq-item,.ampstart-sidebar .ampstart-nav-item,.ampstart-sidebar .ampstart-social-follow{margin:0 0 1.5rem}.ampstart-sidebar .ampstart-nav-dropdown{margin:0}.ampstart-sidebar .ampstart-navbar-trigger{line-height:inherit}.ampstart-navbar-trigger svg{pointer-events:none}.ampstart-related-article-section{border-color:#4a4a4a}.ampstart-related-article-section .ampstart-heading{color:#4a4a4a;font-weight:400}.ampstart-related-article-readmore{color:#000;letter-spacing:0}.ampstart-related-section-items>li{border-bottom:1px solid #4a4a4a}.ampstart-related-section-items>li:last-child{border:none}.ampstart-related-section-items .ampstart-image-with-caption{display:-webkit-box;display:-ms-flexbox;display:flex;-ms-flex-wrap:wrap;flex-wrap:wrap;-webkit-box-align:center;-ms-flex-align:center;align-items:center;margin-bottom:0}.ampstart-related-section-items .ampstart-image-with-caption>amp-img,.ampstart-related-section-items .ampstart-image-with-caption>figcaption{-webkit-box-flex:1;-ms-flex:1;flex:1}.ampstart-related-section-items .ampstart-image-with-caption>figcaption{padding-left:1rem}@media (min-width:40.06rem){.ampstart-related-section-items>li{border:none}.ampstart-related-section-items .ampstart-image-with-caption>figcaption{padding:1rem 0}.ampstart-related-section-items .ampstart-image-with-caption>amp-img,.ampstart-related-section-items .ampstart-image-with-caption>figcaption{-ms-flex-preferred-size:100%;flex-basis:100%}}.ampstart-social-box{display:-webkit-box;display:-ms-flexbox;display:flex}.ampstart-social-box>amp-social-share{background-color:#000}.ampstart-icon{fill:#003f93}.ampstart-input{width:100%}main .ampstart-social-follow{margin-left:auto;margin-right:auto;width:315px}main .ampstart-social-follow li{-webkit-transform:scale(1.8);transform:scale(1.8)}h1+.ampstart-byline time{font-size:18px;font-weight:400}.ampstart-subtitle{text-transform:uppercase}.content-body iframe{max-width:100%}.margin-top-15{margin-top:15px}.margin-top-10{margin-top:10px}.text-red{color:red}.amp-social-share{font-size:14px;padding:5px;width:32%}amp-social-share{background-size:20px}.amp-social-list{position:absolute;bottom:30px}.followus{margin-top:-10px;font-weight:700}.box-artikel-terkait-images amp-img{width:80px;height:80px}.box-artikel-terkait{border-bottom:1px solid #ccc;padding-bottom:2px;padding-top:10px}.box-artikel-terkait-images{float:left}.box-artikel-terkait-images amp-img img{object-fit:cover}.box-artikel-terkait-description small{font-size:11px}.box-artikel-terkait-description p{font-weight:700;font-size:14px}.box-artikel-terkait a{text-decoration:none}.feature-images amp-img img{object-fit:cover}.ads{width:320px;height:auto;text-align:center;margin:70px auto auto}.ads-300{height:250px}.ads-300,.ads-600{width:300px;text-align:center;margin:10px auto auto}.ads-600{height:600px}footer{background-color:#fff}footer ul{margin:0;padding:0}footer a{color:#fff;font-size:12px;font-weight:400;text-transform:none}footer li{list-style:none}.footer-copyright{color:#fff;font-size:14px;text-align:center;padding:10px;background-color:#1d1d1b}.feature-images-video{background-color:#000;padding:20px 0}.content-body p{margin:10px 0}.align-center-button{display:flex;align-items:center;justify-content:center;flex-direction:row;width:100%}amp-web-push-widget .subscribe{display:flex;flex-direction:row;align-items:center;border-radius:2px;border:1px solid #007ae2;padding:6px 20px;font-size:12px;margin:15px 0 0;background:#0e82e5;color:#fff}amp-web-push-widget .subscribe,amp-web-push-widget .unsubscribe{cursor:pointer;outline:0;font-weight:400;-webkit-tap-highlight-color:transparent}amp-web-push-widget .unsubscribe{border-radius:2px;border:1px solid #b3b3b3;margin:0;padding:8px 15px;font-size:15px;background:#bdbdbd;color:#555}amp-web-push-widget .subscribe .subscribe-icon{margin-right:10px}amp-web-push-widget .subscribe:active{transform:scale(.99)}
Akhirnya Vaksin untuk Cegah Jenis Kanker Ini Ditemukan Kanker merupakan penyakit tidak menular yang mematikan, kabar baiknya peneliti di Scripps Research Institute di La Jolla, Calif, dan University of Texas di Dallas, menemukan potensi pencegahan perburukan kanker melanoma lewat vaksin seperti dilansirNypost .
Bahkan keberhasikan vaksin yang telah diuji coba ke tikus ini mencapai 100 persen dalam mengobati melanoma agresif.
Untuk mendapatkan temuan ini, peneliti memberi tikus yang menderita melanoma, obat imunoterapi kanker anti-PD-L1, yang dapat mencegah sel-sel tumor menyerang sistem kekebalan mereka.
Selain itu, penelitian ini juga menguji tikus yang diberi Diprovocim, senyawa kimia yang dimaksudkan untuk menggembleng sistem kekebalan layaknya vaksin. Hasilnya tikus yang divaksin memiliki tingkat kelangsungan hidup sebesar 100 persen. Bahkan vaksinasi ini terbukti dapat menggagalkan pertumbuhan tumor kanker pada tikus yang diuji.
Meski hasil penelitian ini menggembirakan, Dale Boger, seorang ahli kimia di Scripps dan sekaligus penanggung jawab penelitian ini mengatakan perlu penelitian lebih lanjut untuk menentukan efektivitas vaksin ini pada manusia.
"Sama seperti vaksin yang dapat melatih tubuh untuk melawan zat asing yang masuk ke dalam tubuh, vaksin ini melatih sistem kekebalan untuk menghabisi tumor. Temuan kami berpotensi menjadi salah satu solusi dalam pengobatan kanker melanoma," ujar Dale Boger.
Menurut American Cancer Society, lebih dari 9.000 orang meninggal karena kanker kulit melanoma setiap tahun. Di Amerika Serikat prevalensi kanker melanoma mencapai satu persen dari total populasi.
Tapi potensi pencegahan perburukan kanker melanoma bisa dilakukan lewat lewat vaksin.
Berita Terkait: